Results 141 to 150 of about 1,543,950 (339)

Evolving Platinum‐Copper Nanostructures for Enhanced Photothermal Therapy and Controlled Copper Release in Cancer Therapy

open access: yesAdvanced Functional Materials, EarlyView.
Platinum‐Copper bimetallic nanoparticles may evolve depending on their synthesis under tumor microenvironment conditions and play a dual role as chemotherapeutic agents after releasing Cu ions and as near infrared photothermal agents with the Pt‐rich remaining frames.
Jose I. Garcia‐Peiro   +7 more
wiley   +1 more source

ANTIBODY RESPONSE OF HUMAN BEINGS FOLLOWING VACCINATION WITH INFLUENZA VIRUSES [PDF]

open access: bronze, 1942
George K. Hirst   +3 more
openalex   +1 more source

A Sustainable Biotechnology Approach for Mineral Separation

open access: yesAdvanced Functional Materials, EarlyView.
Silver‑binding peptides are first identified through phage‐display screening, and then engineered into multifunctional and responsive peptides or proteins. These tailored biomolecules can selectively capture and aggregate silver particles or ions from complex mixtures, enabling rapid and efficient silver separation and recovery.
Guangze Yang   +7 more
wiley   +1 more source

Human Papillomavirus Infection: Prevention, Barriers to Vaccination, and the Need for Education [PDF]

open access: yes, 2016
While there is no known cure for HPV, prophylactic vaccination provides an effective method of primary prevention against HPV-related diseases. However, many females and males never receive the HPV vaccine as recommended.
Kessler, Theresa A
core   +2 more sources

Cholesterol in mRNA‐Lipid Nanoparticles can be Replaced with the Synthetic Mycobacterial Monomycoloyl Glycerol Analogue MMG‐1

open access: yesAdvanced Functional Materials, EarlyView.
This study demonstrates that cholesterol in messenger RNA‐lipid nanoparticles (mRNA‐LNPs) can be completely replaced with an immunopotentiating lipid, i.e., a synthetic analogue of the C‐type lectin receptor agonist monomycoloyl glycerol (MMG‐1), without compromising physicochemical properties, in vivo transfection efficiency, and immunogenicity of the
Abhijeet G. Lokras   +19 more
wiley   +1 more source

Fighting Flu Fatigue [PDF]

open access: yes, 2010
Reviews responses to the 2009 H1N1 flu, including vaccination rates by state. Recommends steps to increase seasonal flu vaccination rates to boost preparations for flu pandemics and enhance prevention and response efforts for other health ...

core  

Microbubble‐Controlled Delivery of Biofilm‐Targeting Nanoparticles to Treat MRSA Infection

open access: yesAdvanced Functional Materials, EarlyView.
Here, an effective strategy using microbubble (MB)‐controlled delivery of biofilm‐targeting nanoparticles (BTNs) for removal and therapy of methicillin‐resistant Staphylococcus aureus (MRSA) biofilm infections is introduced. In vivo delivery of MB with BTN is demonstrated to silence key bacterial genes involved in biofilm formation (icaA), bacterial ...
Ju Yeon Chung   +6 more
wiley   +1 more source

Measles vaccination in lung transplant candidates

open access: yesFrontiers in Immunology
BackgroundThe incidence of measles is now increasing. Measles is especially dangerous for high-risk individuals, including lung transplant candidates with severe progressive bronchopulmonary disorders.ObjectiveThe objective of this study was to ...
Мikhail P. Kostinov   +10 more
doaj   +1 more source

Identification of a small molecule that primes the type I interferon response to cytosolic DNA

open access: yesScientific Reports, 2017
The type I interferon response plays a pivotal role in host defense against infectious agents and tumors, and promising therapeutic approaches rely on small molecules designed to boost this system.
Samira Khiar   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy